HOME >> BIOLOGY >> NEWS
New U. of Colorado electron microscopes provide cell images never seen before

The University of Colorado at Boulder has acquired two new state-of-the-art electron microscopes and a suite of complementing computers that are providing three-dimensional images of cellular structures that have never been seen before.

The microscopes, which were purchased for a total of nearly $3 million, are furthering the reputation of the molecular, cellular and developmental biology department as a nationally recognized research center, said Distinguished Professor Richard McIntosh. The department already has a three-story tall, 1 million-volt electron microscope that has been used by researchers from around the world since it was acquired by former faculty member Keith Porter in 1972.

"These new instruments are supported by a small fleet of exceptionally powerful personal computers that run programs developed by CU-Boulder researchers to reconstruct parts of cells in 3-D using the mathematics of tomography, just as doctors use a CAT scan or MRI to visualize the head or chest of a patient," said McIntosh. The resulting images reveal aspects of cellular organization at unprecedented resolution in 3-D.

"The Laboratory for Three-Dimensional Cell Structure uses electron microscopy to investigate the internal organization of cells," said McIntosh, who directs
the facility. "What makes the addition of these new microscopes important is
that we are able to image portions of cells in three dimensions at a resolution
that has not previously been possible."

The 3-D lab has been developing technologies with which to image cells at high resolution, using computer-facilitated image processing to reconstruct and visualize cells from a wide range of organisms from both normal and diseased states, said McIntosh.

"The images are providing scientists with a new window on the structural details of cellular organelles, thereby settling some long-standing controversies about how various cellular processes work," he said. "E
'"/>

Contact: Richard McIntosh
dick@stripe.colorado.edu
303-492-8533
University of Colorado at Boulder
19-Nov-2001


Page: 1 2 3

Related biology news :

1. Colorado River Conference Aug. 26
2. Hidden cost of Colorado River diversions is $2.4 billion annually
3. Earstones tell fishes tale of early life in the Colorado River estuary
4. U. of Colorado professor pioneering tissue engineering from knees to hearts to brains
5. University of Colorado archaeologist, colleagues hot on the trail of ancient Persian warships
6. U. of Colorado team developing Flu Chip for fast, accurate diagnosis
7. Microbes active in Colorado snows fuel tundra ecosystem
8. New Colorado U. study shows increase in fungal metabolism under the snow
9. Changing global nitrogen cycle impacting human health, says Colorado University-led study
10. U. of Colorado scientists discover four new kingdoms of life
11. U.of Colorado researchers solve molecular structure involved with heart disease

Post Your Comments:
(Date:5/21/2013)... the world,s largest scientific society, invites news media ... September 8-12, 2013, in Indianapolis, Ind. It will ... at area hotels. , With more than 7,100 ... from astronomy to zoology ― the meeting ... rich assortment of spot news and feature possibilities. ...
(Date:5/21/2013)... which alter the way genes function without changing ... in the blood of pregnant women during any ... depression in the weeks after giving birth, and ... , The findings of the small study involving ... journal Molecular Psychiatry . , "Postpartum depression ...
(Date:5/20/2013)... suggests that a compound abundant in the Mediterranean diet ... , By altering a very specific step in gene ... cells that die as scheduled. , One way that ... would cause them to die on a regular cycle ... cells, led by Ohio State University researchers, found that ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
(Date:5/21/2013)... May 21, 2013 According to ... ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the ... and is expected to grow at a CAGR of ... value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
(Date:5/21/2013)... Revolutionary Science, the manufacturer of the ... today that they have expanded their colony counter product ... IntelliCount, InCount and ImpressCount. These affordable colony counters ... in food microbiology and pharmaceutical manufacturing. , The previously ... A bright white enclosure with jet black accents represent ...
(Date:5/21/2013)... MA (PRWEB) May 21, 2013 Possible mold ... And so, according to a report from eagletribune.com posted May ... mold. In case the result is positive, My Cleaning Products ... using harmful chemical ingredients. , It was said in the ... re-infestation in the campus sparked after a first-grade classroom ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
Cached News: